• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

‘Why not take a risk’ attitude widespread among patients and providers, GW study finds

Bioengineer by Bioengineer
May 31, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WASHINGTON (May 31, 2018)–"Antibiotics can't hurt. They might even make me feel better. Why not take a risk?" You may have had similar thoughts when sick with the flu or common cold. Your doctor may think so too.

A new study led by David Broniatowski, an assistant professor in the George Washington University's department of engineering management and systems engineering, finds the "Why not take a risk?" mentality is widespread among patients and medical care providers. Many in both groups believe that antibiotics "can't hurt" patients with flu or cold symptoms. They held this belief even though they knew antibiotics have side effects. Education alone doesn't seem to help: many knew antibiotics don't work against viruses. However, providers still believed the antibiotics might help patients feel better.

Patients and providers who use antibiotics may not be behaving irrationally. "When you're feeling sick, you just want to feel better as soon as possible and the side effects from antibiotics look extremely mild in comparison," Dr. Broniatowski said. "There's always that extremely rare possibility that your disease actually is bacterial."

However, this "Why not take a risk?" belief may be leading to unnecessary prescribing and to the spread of superbugs, which have caused 23,000 deaths and 2 million illnesses nationwide. According to the Centers for Disease Control and Prevention, the total cost to treat superbugs exceeds $20 billion annually.

"People may be acting strategically – trying to hedge their bets – when they expect or prescribe antibiotics," Dr. Broniatowski said. "Unfortunately, this individually-rational action leads to negative consequences for society."

The team behind the study included researchers from GW; the Center For Disease Dynamics, Economics & Policy; Johns Hopkins University; University of California, Davis; and Cornell University. They surveyed 149 clinicians and 225 patients from two large urban academic hospitals, and 519 online nonpatient subjects to determine whether providers share patients' rationales for antibiotic use. The research, "Patients' and Clinicians' Perceptions of Antibiotic Prescribing for Upper Respiratory Infections in the Acute Care Setting," appeared in May in the journal Medical Decision Making.

Dr. Broniatowski and his colleagues hope a better understanding of this issue will lead to the development of communication strategies directed to both patients and providers that can be used to reduce inappropriate prescribing, thus alleviating antibiotic resistance.

###

Media Contact

Timothy Pierce
[email protected]
202-994-5647
@GWtweets

http://www.gwu.edu

Share12Tweet8Share2ShareShareShare2

Related Posts

First-in-Class Dual HIF Inhibitors Eradicate Breast, Colorectal, Melanoma, and Prostate Tumors in Mice Combined with Immunotherapy

April 2, 2026

Blocking RUNX1/2 Boosts Fat Tissue Thermogenesis

April 2, 2026

Cysteine Sulfenylation of p-GSK-3β Drives Liver Insulin Resistance

April 2, 2026

First Human Trial of Implant for Brain Pressure Monitoring

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Breakthrough in Room-Temperature Drying Provides Affordable Method to Stabilize Functional Proteins

First-in-Class Dual HIF Inhibitors Eradicate Breast, Colorectal, Melanoma, and Prostate Tumors in Mice Combined with Immunotherapy

Electrochemical Ring-Opening Enables Programmable Strained-Ring Functionalization

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.